Co-Authors
This is a "connection" page, showing publications co-authored by Flora Peyvandi and Alessandra Bandera.
Connection Strength
0.749
-
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. J Allergy Clin Immunol. 2021 Feb; 147(2):561-566.e4.
Score: 0.229
-
Complement activation and endothelial perturbation parallel COVID-19 severity and activity. J Autoimmun. 2021 01; 116:102560.
Score: 0.228
-
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy. Microbiol Spectr. 2021 10 31; 9(2):e0054921.
Score: 0.060
-
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment. Intern Emerg Med. 2022 01; 17(1):303-306.
Score: 0.060
-
Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595]. J Autoimmun. 2021 Jun; 120:102646.
Score: 0.059
-
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19. J Autoimmun. 2021 02; 117:102595.
Score: 0.058
-
Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
Score: 0.055